Investment
Features
FeesSafety
Academy
More
Pluang+

Compare SK Telecom Co. Ltd. Common Stock (SKM) vs Sanofi SA (SNY) Price & Performance

SK Telecom Co. Ltd. Common StockTrade

Price performance (Past 24H)

Key statistics

SK Telecom Co. Ltd. Common Stock vs Sanofi SA — how do they compare? SK Telecom Co. Ltd. Common Stock trades at $34.24 (market cap $13.36B), while Sanofi SA trades at $40.07 (market cap $95.18B). The key difference: Sanofi SA is far larger — about 7.1× SK Telecom Co. Ltd. Common Stock's market cap, and Sanofi SA pays the higher dividend (6.01%). Which is the better fit depends on your goals — on Pluang, investors hold SK Telecom Co. Ltd. Common Stock for 1 Days and Sanofi SA for 94 Days on average.

SKMSNY
Market Cap
$13.36B$95.18B
Volume
1,302,0422,995,646
Sector
MediaHealth
52-Week High
$46.00$52.34
52-Week Low
$19.68$39.51
Typical Hold Time
1 Days94 Days
Enterprise Value
$19.41B$114.48B
Dividend Yield
2.85%6.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

SK Telecom Co. Ltd. Common Stock

No Aura AI signal available yet.

Sanofi SA

Sanofi (SNY) trades at $40.07, down 0.32% on the day, with a bearish technical signal from moving averages. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $1.21 exceeding the $1.10 estimate. Revenue for 2025 reached $46.72 billion, with a net income margin of 16.72%. Recent news highlights a significant $8 billion immunology alliance expansion with Regeneron, signaling strategic growth initiatives.

The outlook is mixed; solid profitability and a strategic partnership provide upside potential, but a projected net income decline to $4.0 billion in 2026 and bearish technical indicators pose risks. Analyst sentiment is cautiously optimistic with a 44% buy rating, though investors should monitor execution of new collaborations and patent expiration impacts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SKM

No sentiment data available yet.

SNY
35% Buy65% Sell
Avg holding period · 94 Days

Top news

Latest headlines on both assets

About SK Telecom Co. Ltd. Common Stock

SK Telecom is a South Korean telecommunications company providing mobile, broadband, and digital services. It also develops services in areas such as AI, cloud, and data centers.

Read more on SKM →

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY →